{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:10:34Z","timestamp":1782832234108,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00210-023-02531-4","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T10:02:32Z","timestamp":1685440952000},"page":"3243-3252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vivo evaluation of nephrotoxicity and neurotoxicity of colistin formulated with sodium deoxycholate sulfate in a mice model"],"prefix":"10.1007","volume":"396","author":[{"given":"Muhammad Ali Khumaini Mudhar","family":"Bintang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongdee","family":"Nopparat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapol","family":"Srichana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"publisher","unstructured":"Ahmed MAEE, Doi Y, Tian G, et al (2020) Colistin and its role in the Era of antibiotic resistance\u202f: an extended review. Emerg Microbes Infect 9:868\u2013885. https:\/\/doi.org\/10.1080\/22221751.2020.1754133","DOI":"10.1080\/22221751.2020.1754133"},{"key":"2531_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","volume":"31","author":"AZ Bialvaei","year":"2015","unstructured":"Bialvaei AZ, Samadi Kafil H (2015) Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 31:707\u2013721. https:\/\/doi.org\/10.1185\/03007995.2015.1018989","journal-title":"Curr Med Res Opin"},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11096-015-0077-4","volume":"37","author":"BOM Claus","year":"2015","unstructured":"Claus BOM, Snauwaert S, Haerynck F et al (2015) Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients. Int J Clin Pharm 37:555\u2013558. https:\/\/doi.org\/10.1007\/s11096-015-0077-4","journal-title":"Int J Clin Pharm"},{"key":"2531_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3109\/15376516.2012.704956","volume":"22","author":"C Dai","year":"2012","unstructured":"Dai C, Li J, Lin W et al (2012) Electrophysiology and ultrastructural changes in mouse sciatic nerve associated with colistin sulfate exposure. Toxicol Mech Methods 22:592\u2013596. https:\/\/doi.org\/10.3109\/15376516.2012.704956","journal-title":"Toxicol Mech Methods"},{"key":"2531_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.etp.2013.01.008","volume":"65","author":"C Dai","year":"2013","unstructured":"Dai C, Li J, Li J (2013) New insight in colistin induced neurotoxicity with the mitochondrial dysfunction in mice central nervous tissues. Exp Toxicol Pathol 65:941\u2013948. https:\/\/doi.org\/10.1016\/j.etp.2013.01.008","journal-title":"Exp Toxicol Pathol"},{"key":"2531_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/bcpt.12272","volume":"115","author":"C Dai","year":"2014","unstructured":"Dai C, Tang S, Li J et al (2014) Effects of Colistin on the Sensory Nerve Conduction Velocity and F-wave in Mice. Basic Clin Pharmacol Toxicol 115:577\u2013580. https:\/\/doi.org\/10.1111\/bcpt.12272","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2531_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1021\/acsinfecdis.9b00341","volume":"6","author":"C Dai","year":"2020","unstructured":"Dai C, Xiao X, Zhang Y et al (2020) Curcumin Attenuates Colistin-Induced Peripheral Neurotoxicity in Mice. ACS Infect Dis 6:715\u2013724. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00341","journal-title":"ACS Infect Dis"},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/membranes4030333","volume":"4","author":"S De","year":"2014","unstructured":"De S, Kuwahara S, Saito A (2014) The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells. Membranes (basel) 4:333\u2013335. https:\/\/doi.org\/10.3390\/membranes4030333","journal-title":"Membranes (basel)"},{"key":"2531_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/FTD.0000000000000172","volume":"37","author":"AC Dijkmans","year":"2015","unstructured":"Dijkmans AC, Wilms EB, Kamerling IMC et al (2015) Colistin: Revival of an Old Polymyxin Antibiotic. Ther Drug Monit 37:419\u2013427. https:\/\/doi.org\/10.1097\/FTD.0000000000000172","journal-title":"Ther Drug Monit"},{"key":"2531_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2018.08.012","volume":"294","author":"NE Edrees","year":"2018","unstructured":"Edrees NE, Galal AAA, Abdel Monaem AR et al (2018) Curcumin alleviates colistin-induced nephrotoxicity and neurotoxicity in rats via attenuation of oxidative stress, inflammation and apoptosis. Chem Biol Interact 294:56\u201364. https:\/\/doi.org\/10.1016\/j.cbi.2018.08.012","journal-title":"Chem Biol Interact"},{"key":"2531_CR11","doi-asserted-by":"publisher","unstructured":"Falagas ME, Kasiakou SK (2006) Toxicity of polymyxins: A systematic review of the evidence from old and recent studies. Crit Care 10:1\u201318.  https:\/\/doi.org\/10.1186\/cc3995","DOI":"10.1186\/cc3995"},{"key":"2531_CR12","doi-asserted-by":"publisher","unstructured":"Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M (2019) Molecular Mechanisms of Colistin-Induced Nephrotoxicity. Molecules 24:653. https:\/\/doi.org\/10.3390\/molecules24030653","DOI":"10.3390\/molecules24030653"},{"key":"2531_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijpharm.2014.05.066","volume":"471","author":"KN Gangadhar","year":"2014","unstructured":"Gangadhar KN, Adhikari K, Srichana T (2014) Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Int J Pharm 471:430\u2013438. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.066","journal-title":"Int J Pharm"},{"key":"2531_CR14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s40262-017-0561-1","volume":"56","author":"N Gr\u00e9goire","year":"2017","unstructured":"Gr\u00e9goire N, Aranzana-Climent V, Magr\u00e9ault S et al (2017) Clinical Pharmacokinetics and Pharmacodynamics of Colistin. Clin Pharmacokinet 56:1441\u20131460. https:\/\/doi.org\/10.1007\/s40262-017-0561-1","journal-title":"Clin Pharmacokinet"},{"key":"2531_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ja.2013.111.A","volume":"67","author":"C Hill","year":"2014","unstructured":"Hill C, Jain A, Takemoto H et al (2014) A secondary mode of action of polymyxins against Gram- negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot (tokyo) 67:147\u2013151. https:\/\/doi.org\/10.1038\/ja.2013.111.A","journal-title":"J Antibiot (tokyo)"},{"key":"2531_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000363495","volume":"37","author":"PM Honor\u00e9","year":"2014","unstructured":"Honor\u00e9 PM, Jacobs R, Joannes-Boyau O et al (2014) Continuous renal replacement therapy-related strategies to avoid colistin toxicity: A clinically orientated review. Blood Purif 37:291\u2013295. https:\/\/doi.org\/10.1159\/000363495","journal-title":"Blood Purif"},{"key":"2531_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xphs.2022.02.011","volume":"000","author":"S Kaewpaiboon","year":"2022","unstructured":"Kaewpaiboon S, Srichana T (2022) Formulation Optimization and Stability of Polymyxin B Based on Sodium Deoxycholate Sulfate Micelles. J Pharm Sci 000:1\u20139. https:\/\/doi.org\/10.1016\/j.xphs.2022.02.011","journal-title":"J Pharm Sci"},{"key":"2531_CR18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1517\/14740338.2015.1088520","volume":"14","author":"T Kalesidis","year":"2015","unstructured":"Kalesidis T, Falagas ME (2015) The safety of polymyxin antibiotics Theodoros. Expert Opin Drug Saf 14:1687\u20131701. https:\/\/doi.org\/10.1517\/14740338.2015.1088520","journal-title":"Expert Opin Drug Saf"},{"key":"2531_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1517\/14656566.2014.914172","volume":"15","author":"I Karaiskos","year":"2014","unstructured":"Karaiskos I, Giamarellou H (2014) Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: Current and emerging therapeutic approaches. Expert Opin Pharmacother 15:1351\u20131370. https:\/\/doi.org\/10.1517\/14656566.2014.914172","journal-title":"Expert Opin Pharmacother"},{"key":"2531_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17425255.2017.1230200","volume":"13","author":"I Karaiskos","year":"2017","unstructured":"Karaiskos I, Souli M, Galani I, Giamarellou H (2017) Colistin: still a lifesaver for the 21st century? Expert Opin Drug Metab Toxicol 13:59\u201371. https:\/\/doi.org\/10.1080\/17425255.2017.1230200","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2531_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/toxsci\/kft247","volume":"137","author":"ND Keirstead","year":"2014","unstructured":"Keirstead ND, Wagoner MP, Bentley P et al (2014) Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol Sci 137:278\u2013291. https:\/\/doi.org\/10.1093\/toxsci\/kft247","journal-title":"Toxicol Sci"},{"key":"2531_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1517\/14740338.2015.1088520","volume":"14","author":"T Kelesidis","year":"2015","unstructured":"Kelesidis T, Falagas ME (2015) The safety of polymyxin antibiotics. Expert Opin Drug Saf 14:1687\u20131701. https:\/\/doi.org\/10.1517\/14740338.2015.1088520","journal-title":"Expert Opin Drug Saf"},{"key":"2531_CR23","doi-asserted-by":"publisher","first-page":"104091","DOI":"10.1016\/j.jddst.2022.104091","volume":"79","author":"MA KhumainiMudharBintang","year":"2023","unstructured":"KhumainiMudharBintang MA, Tipmanee V, Srichana T (2023) Colistin sulfate-sodium deoxycholate sulfate micelle formulations; molecular interactions, cell nephrotoxicity and bioactivity. J Drug Deliv Sci Technol 79:104091. https:\/\/doi.org\/10.1016\/j.jddst.2022.104091","journal-title":"J Drug Deliv Sci Technol"},{"key":"2531_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2020.00755","volume":"11","author":"M Kitada","year":"2020","unstructured":"Kitada M, Xu J, Ogura Y et al (2020) Manganese superoxide dismutase dysfunction and the pathogenesis of kidney disease. Front Physiol 11:1\u201316. https:\/\/doi.org\/10.3389\/fphys.2020.00755","journal-title":"Front Physiol"},{"key":"2531_CR25","doi-asserted-by":"publisher","first-page":"110374","DOI":"10.1016\/j.colsurfb.2019.110374","volume":"182","author":"S Madhumanchi","year":"2019","unstructured":"Madhumanchi S, Suedee R, Nakpheng T et al (2019) Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier \u2018sodium deoxycholate sulfate.\u2019 Colloids Surfaces B Biointerfaces 182:110374. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110374","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"2531_CR26","doi-asserted-by":"publisher","first-page":"119265","DOI":"10.1016\/j.ijpharm.2020.119265","volume":"581","author":"S Madhumanchi","year":"2020","unstructured":"Madhumanchi S, Suedee R, Kaewpiboon S et al (2020) Effect of sodium deoxycholate sulfate on outer membrane permeability and neutralization of bacterial lipopolysaccharides by polymyxin B formulations. Int J Pharm 581:119265. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119265","journal-title":"Int J Pharm"},{"key":"2531_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciu213","volume":"59","author":"RL Nation","year":"2014","unstructured":"Nation RL, Velkov T, Li J (2014) Colistin and polymyxin B: Peas in a pod, or chalk and cheese? Clin Infect Dis 59:88\u201394. https:\/\/doi.org\/10.1093\/cid\/ciu213","journal-title":"Clin Infect Dis"},{"key":"2531_CR28","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.2146\/ajhp150876","volume":"74","author":"LH Nazer","year":"2017","unstructured":"Nazer LH, Anabtawi N (2017) Optimizing colistin dosing: Is a loading dose necessary? Am J Heal Pharm 74:e9\u2013e16. https:\/\/doi.org\/10.2146\/ajhp150876","journal-title":"Am J Heal Pharm"},{"key":"2531_CR29","unstructured":"Neill JO\u2019 (2014) Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations The Review on Antimicrobial Resistance\u00a0Chaired. Rev Antimicrob Resist 20:1\u201316"},{"key":"2531_CR30","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1586\/14787210.2015.1070097","volume":"13","author":"JK Ortwine","year":"2015","unstructured":"Ortwine JK, Sutton JD, Kaye KS, Pogue JM (2015) Strategies for the safe use of colistin. Expert Rev Anti Infect Ther 13:1237\u20131247. https:\/\/doi.org\/10.1586\/14787210.2015.1070097","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2531_CR31","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1128\/AAC.00343-13","volume":"57","author":"G Ozkan","year":"2013","unstructured":"Ozkan G, Ulusoy S, Orem A et al (2013) How does colistin-induced nephropathy develop and can it be treated? Antimicrob Agents Chemother 57:3463\u20133469. https:\/\/doi.org\/10.1128\/AAC.00343-13","journal-title":"Antimicrob Agents Chemother"},{"key":"2531_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00134-010-2038-7","volume":"37","author":"E Ozyilmaz","year":"2011","unstructured":"Ozyilmaz E, Ebinc FA, Derici U et al (2011) Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med 37:141\u2013146. https:\/\/doi.org\/10.1007\/s00134-010-2038-7","journal-title":"Intensive Care Med"},{"key":"2531_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics8020038","volume":"8","author":"F Perez","year":"2019","unstructured":"Perez F, El Chakhtoura NG, Yasmin M, Bonomo RA (2019) Polymyxins: To combine or not to combine? Antibiotics 8:1\u201313. https:\/\/doi.org\/10.3390\/antibiotics8020038","journal-title":"Antibiotics"},{"key":"2531_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmi.2017.02.023","volume":"23","author":"JM Pogue","year":"2017","unstructured":"Pogue JM, Ortwine JK, Kaye KS (2017) Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing. Clin Microbiol Infect 23:229\u2013233. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.023","journal-title":"Clin Microbiol Infect"},{"key":"2531_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1152\/ajprenal.00266.2003","volume":"286","author":"R Sunami","year":"2004","unstructured":"Sunami R, Sugiyama H, Wang DH et al (2004) Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol - Ren Physiol 286:2\u20135. https:\/\/doi.org\/10.1152\/ajprenal.00266.2003","journal-title":"Am J Physiol - Ren Physiol"},{"key":"2531_CR36","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1128\/AAC.00254-13","volume":"57","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Yamaguchi H, Ogura J et al (2013) Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother 57:6319\u20136324. https:\/\/doi.org\/10.1128\/AAC.00254-13","journal-title":"Antimicrob Agents Chemother"},{"key":"2531_CR37","doi-asserted-by":"publisher","unstructured":"Temboot P, Kaewpaiboon S, Tinpun K, et al (2020) Potential of sodium deoxycholate sulfate as a carrier for polymyxin B: Physicochemical properties, bioactivity and in vitro safety. J Drug Deliv Sci Technol 58:101779. https:\/\/doi.org\/10.1016\/j.jddst.2020.101779","DOI":"10.1016\/j.jddst.2020.101779"},{"key":"2531_CR38","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1016\/j.xphs.2017.08.013","volume":"106","author":"F Usman","year":"2017","unstructured":"Usman F, Ul-Haq Z, Khalil R et al (2017) Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach. J Pharm Sci 106:3574\u20133582. https:\/\/doi.org\/10.1016\/j.xphs.2017.08.013","journal-title":"J Pharm Sci"},{"key":"2531_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13346-019-00662-x","volume":"10","author":"F Usman","year":"2020","unstructured":"Usman F, Nopparat J, Javed I, Srichana T (2020) Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models. Drug Deliv Transl Res 10:59\u201369. https:\/\/doi.org\/10.1007\/s13346-019-00662-x","journal-title":"Drug Deliv Transl Res"},{"key":"2531_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijantimicag.2016.07.023","volume":"49","author":"KZ Vardakas","year":"2017","unstructured":"Vardakas KZ, Falagas ME (2017) Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis. Int J Antimicrob Agents 49:233\u2013238. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.07.023","journal-title":"Int J Antimicrob Agents"},{"key":"2531_CR41","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1128\/AAC.01101-07","volume":"52","author":"SJ Wallace","year":"2008","unstructured":"Wallace SJ, Li J, Nation RL et al (2008) Subacute toxicity of colistin methanesulfonate in rats: Comparison of various intravenous dosage regimens. Antimicrob Agents Chemother 52:1159\u20131161. https:\/\/doi.org\/10.1128\/AAC.01101-07","journal-title":"Antimicrob Agents Chemother"},{"key":"2531_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijpharm.2015.05.069","volume":"490","author":"W Wang","year":"2015","unstructured":"Wang W (2015) Tolerability of hypertonic injectables. Int J Pharm 490:308\u2013315. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.05.069","journal-title":"Int J Pharm"},{"key":"2531_CR43","doi-asserted-by":"publisher","unstructured":"Yu Z, Qin W, Lin J, et al (2015) Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed Res Int 2015:679109. https:\/\/doi.org\/10.1155\/2015\/679109","DOI":"10.1155\/2015\/679109"},{"key":"2531_CR44","doi-asserted-by":"publisher","unstructured":"Zavascki AP, Nation RL (2017) Nephrotoxicity of polymyxins: Is there any difference between colistimethate and polymyxin B? Antimicrob Agents Chemother 61:e02319\u201316. https:\/\/doi.org\/10.1128\/AAC.02319-16","DOI":"10.1128\/AAC.02319-16"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02531-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02531-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02531-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:13:33Z","timestamp":1697004813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02531-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02531-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed with the approval of the animal ethics committee, Prince of Songkla University (MHESI 68014\/1895, Ref. 81\/2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent to the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}